Dexamethasone implant for the treatment of persistent diabetic macular oedema despite long-term treatment with bevacizumab

Grants

Funding Acknowledgements

The authors would like to acknowledge Dr Jeremy Smith, Mr Paul Power and Ms Anette Kifly as safety monitors for the trial, and Ms Jaclyn Brant, Ms Roxy Medina and Ms Sutha Sanmugasundaram for their assistance with data collection and maintaining the databases. SSW was financially supported by Australian National Health and Medical Research Council (NHMRC) and Novartis; and was the recipient of gifts, honoraria, travel reimbursement or patent from Allergan, Bayer and Novartis. MCG was Consultant and financially supported by Allergan, Bayer and Novartis. LLL was Consultant and financially supported by Abbvie, Allergan and Bayer; and received financial support from Novartis. HM was Consultant and financially supported by Allergan, Bayer and Novartis. SF-B was Consultant and financially supported by Allergan, Bayer and Novartis.